Article info
Pancreas
Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft model
- Dr D A Vallera, University of Minnesota Cancer Center, MMC: 367, Minneapolis, MN 55455, USA; valle001{at}umn.edu
Citation
Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft model
Publication history
- Revised November 30, 2007
- Accepted December 1, 2007
- First published January 25, 2008.
Online issue publication
August 24, 2016
Article Versions
- Previous version (24 August 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2008 BMJ Publishing Group and British Society of Gastroenterology